Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study

BackgroundAlthough lifestyle factors have been studied in relation to individual non-communicable diseases (NCDs), their association with development of a subsequent NCD, defined as multimorbidity, has been scarcely investigated. The aim of this study was to investigate associations between five lifestyle factors and incident multimorbidity of cancer and cardiometabolic diseases.MethodsIn this prospective cohort study, 291,778 participants (64% women) from seven European countries, mostly aged 43 to 58 years and free of cancer, cardiovascular disease (CVD), and type 2 diabetes (T2D) at recruitment, were included. Incident multimorbidity of cancer and cardiometabolic diseases was defined as developing subsequently two diseases including first cancer at any site, CVD, and T2D in an individual. Multi-state modelling based on Cox regression was used to compute hazard ratios (HR) and 95% confidence intervals (95% CI) of developing cancer, CVD, or T2D, and subsequent transitions to multimorbidity, in relation to body mass index (BMI), smoking status, alcohol intake, physical activity, adherence to the Mediterranean diet, and their combination as a healthy lifestyle index (HLI) score. Cumulative incidence functions (CIFs) were estimated to compute 10-year absolute risks for transitions from healthy to cancer at any site, CVD (both fatal and non-fatal), or T2D, and to subsequent multimorbidity after each of the three NCDs.ResultsDuring a median follow-up of 11 years, 1910 men and 1334 women developed multimorbidity of cancer and cardiometabolic diseases. A higher HLI, reflecting healthy lifestyles, was strongly inversely associated with multimorbidity, with hazard ratios per 3-unit increment of 0.75 (95% CI, 0.71 to 0.81), 0.84 (0.79 to 0.90), and 0.82 (0.77 to 0.88) after cancer, CVD, and T2D, respectively. After T2D, the 10-year absolute risks of multimorbidity were 40% and 25% for men and women, respectively, with unhealthy lifestyle, and 30% and 18% for men and women with healthy lifestyles.ConclusionPre-diagnostic healthy lifestyle behaviours were strongly inversely associated with the risk of cancer and cardiometabolic diseases, and with the prognosis of these diseases by reducing risk of multimorbidity.

Paolo Vineis | Salvatore Panico | Antonio Agudo | Ioanna Tzoulaki | Heiner Boeing | Olov Rolandsson | Patrick Arveux | John Danesh | Elio Riboli | Vivian Viallon | Marije Bakker | Kim Overvad | Gianluca Severi | Elin Thysell | Isabelle Romieu | Cristian Ricci | Adam S. Butterworth | Peter Nilsson | Fulvio Ricceri | Hannah Lennon | Pilar Amiano | J. Danesh | V. Viallon | E. Riboli | P. Vineis | A. Tjønneland | K. Overvad | G. Severi | P. Nilsson | E. Weiderpass | N. Wareham | F. Ricceri | I. Tzoulaki | M. Sweeting | A. Butterworth | I. Romieu | H. Boeing | M. Gunter | R. Kaaks | D. Palli | O. Rolandsson | S. Panico | R. Tumino | M. Jenab | M. Bergmann | P. Arveux | H. Ward | P. Amiano | H. Lennon | A. Olsen | K. Tsilidis | C. Bamia | A. Agudo | C. Ricci | M. Bakker | E. Monninkhof | P. Ferrari | T. Kühn | C. Agnoli | H. Freisling | C. Dahm | Julie A. Schmidt | D. Muller | Elin Thysell | J. Manjer | H. Picavet | V. Bagnardi | Mazda Jenab | Rudolf Kaaks | Anne Tjønneland | Elisabete Weiderpass | Domenico Palli | Claudia Agnoli | Rosario Tumino | Jonas Manjer | Pietro Ferrari | Anja Olsen | Christina C. Dahm | Heinz Freisling | Vincenzo Bagnardi | Michael Sweeting | David Muller | Pauline Bazelle | Marina Kvaskoff | Christina Bamia | Tilman Kühn | Manuela Bergmann | Virginia Menéndez | Maria-Jose Sánchez | Carmen Santiuste | Aurelio Barricarte Gurrea | Tammy Y. N. Tong | Konstantinos K. Tsilidis | Heather Ward | H. Susan J. Picavet | Evelyn Monninkhof | Nick J. Wareham | Marc J. Gunter | M. Kvaskoff | A. B. Gurrea | C. Santiuste | T. Tong | V. Menéndez | M. Sánchez | Pauline Bazelle | P. Ferrari | M. Sánchez | E. Riboli | Heather A. Ward | Carmen Santiuste | T. Tong

[1]  B. Hammock the 2014 , 2014 .

[2]  M. Ezzati Excess weight and multimorbidity: putting people's health experience in risk factor epidemiology. , 2017, The Lancet. Public health.

[3]  Hein Putter,et al.  mstate: An R Package for the Analysis of Competing Risks and Multi-State Models , 2011 .

[4]  A. Blaes,et al.  Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.

[5]  K. Khunti,et al.  Association Between Lifestyle Factors and the Incidence of Multimorbidity in an Older English Population , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  R. Rugulies,et al.  Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe , 2017, The Lancet. Public health.

[7]  T. Consortium Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011 .

[8]  Martin Schumacher,et al.  Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer , 2013, BMC Medical Research Methodology.

[9]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[10]  D. Leroith,et al.  Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Fratiglioni,et al.  The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial. , 2017, Journal of the American Medical Directors Association.

[12]  E. Riboli,et al.  Behavioral and dietary risk factors for noncommunicable diseases. , 2013, The New England journal of medicine.

[13]  K. Overvad,et al.  Healthy Lifestyle and Risk of Cancer in the European Prospective Investigation Into Cancer and Nutrition Cohort Study , 2016, Medicine.

[14]  M. Thomson,et al.  Prioritizing the needs of children in a changing climate , 2018, PLoS medicine.

[15]  Marjan van den Akker,et al.  Comorbidity or multimorbidity: what's in a name ? A review of literature , 1996 .

[16]  N. Sarrafzadegan,et al.  Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. , 2017, Atherosclerosis.

[17]  W. Henley,et al.  Predicting Incident Multimorbidity , 2018, The Annals of Family Medicine.

[18]  Julia H. Rowland,et al.  Anticipating the “Silver Tsunami”: Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[19]  J. Lindström,et al.  Clinical and lifestyle-related risk factors for incident multimorbidity: 10-year follow-up of Finnish population-based cohorts 1982-2012. , 2015, European journal of internal medicine.

[20]  Recinda L. Sherman,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival , 2017, Journal of the National Cancer Institute.

[21]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[22]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[23]  Karin Kraft,et al.  [Type-2 diabetes]. , 2010, MMW Fortschritte der Medizin.

[24]  J. Danesh,et al.  EPIC-Heart: The cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries , 2007, European Journal of Epidemiology.

[25]  Kathryn J Ruddy,et al.  The Epidemiology of Male Breast Cancer , 2015, Current Oncology Reports.

[26]  Linda Davies,et al.  Effectiveness of enhanced communication therapy in the first four months after stroke for aphasia and dysarthria: a randomised controlled trial , 2012, BMJ : British Medical Journal.

[27]  N Slimani,et al.  Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011, Diabetologia.

[28]  Lana Fani,et al.  Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study , 2019, PLoS medicine.

[29]  M. Zwahlen,et al.  Adiposity and cancer risk: new mechanistic insights from epidemiology , 2015, Nature Reviews Cancer.

[30]  U. Ekelund,et al.  Physical activity and gain in abdominal adiposity and body weight: prospective cohort study in 288,498 men and women. , 2011, The American journal of clinical nutrition.

[31]  Re: Collider Bias Is Only a Partial Explanation for the Obesity Paradox. , 2017, Epidemiology.

[32]  Nathalie Huguet,et al.  Health behavior change following chronic illness in middle and later life. , 2012, The journals of gerontology. Series B, Psychological sciences and social sciences.

[33]  A. Renehan,et al.  The Obesity Paradox in Cancer: a Review , 2016, Current Oncology Reports.

[34]  A. Dobson,et al.  Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: A 20-year cohort study , 2018, PLoS medicine.

[35]  K. Khunti,et al.  Type 2 diabetes , 2017, The Lancet.

[36]  Martin Fortin,et al.  Managing patients with multimorbidity: systematic review of interventions in primary care and community settings , 2012, BMJ : British Medical Journal.

[37]  A. Berenguer,et al.  Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study. , 2009, American journal of epidemiology.

[38]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[39]  S. Darby,et al.  Cardiovascular disease after cancer therapy , 2014, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

[40]  A. Alwan Global status report on noncommunicable diseases 2010. , 2011 .

[41]  Jennifer B Dennison,et al.  Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma , 2017, Journal of the National Cancer Institute.

[42]  L. Fratiglioni,et al.  Incidence and Predictors of Multimorbidity in the Elderly: A Population-Based Longitudinal Study , 2014, PloS one.